CyberMDX builds a cyber‑intelligence platform that inventories and manages hospitals' network‑connected assets and devices and monitors threats in real time. The company focuses on securing medical devices and improving hospital network security. Its research arm has discovered vulnerabilities in widely used medical devices and protocols, prompting a Homeland Security alert. CyberMDX was founded four years ago and is based in New York. The company raised $20 million in its latest financing and said it will use the proceeds to roll out its platform across new geographies and markets. Management framed the timing as important given the strain hospitals face from the COVID‑19 pandemic and said the platform can help support the healthcare community. CyberMDX provides a non-intrusive cybersecurity platform that delivers zero-touch visibility, risk management, and threat prevention and detection for medical devices and clinical networks (IoMT). The company focuses on protecting critical hospital assets such as MRIs, patient monitors and infusion pumps that often run legacy, unpatched systems. Its multidisciplinary team includes veterans of Israeli intelligence cyber units, medical device experts, and AI academic leaders; founders named in the article are Amir Magner and Moti Shniberg. CyberMDX emphasizes a scalable, easy-to-deploy solution to ensure operational continuity, patient safety and data protection. The company announced a $10 million Series A led by Pitango Venture Capital with participation from OurCrowd Qure and plans to expand its medical cybersecurity offering to hospitals worldwide.

Total raised

$30M

Funding rounds

2

Latest round

Equity

Latest activity

Apr 2020